| 000 | 01659 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250511164826.0 | ||
| 264 | 0 | _c19770128 | |
| 008 | 197701s 0 0 eng d | ||
| 022 | _a0077-8923 | ||
| 024 | 7 |
_a10.1111/j.1749-6632.1976.tb41720.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStewart, T H | |
| 245 | 0 | 0 |
_aImmunochemotherapy of lung cancer. _h[electronic resource] |
| 260 |
_bAnnals of the New York Academy of Sciences _c1976 |
||
| 300 |
_a436-66 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAntigens, Neoplasm |
| 650 | 0 | 4 |
_aB-Lymphocytes _ximmunology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFreund's Adjuvant _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypersensitivity, Delayed _ximmunology |
| 650 | 0 | 4 | _aImmunotherapy |
| 650 | 0 | 4 |
_aLeucovorin _xtherapeutic use |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethotrexate _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
| 700 | 1 | _aHollinshead, A C | |
| 700 | 1 | _aHarris, J E | |
| 700 | 1 | _aBelanger, R | |
| 700 | 1 | _aCrepeau, A | |
| 700 | 1 | _aHooper, G D | |
| 700 | 1 | _aSachs, H J | |
| 700 | 1 | _aKlaassen, D J | |
| 700 | 1 | _aHirte, W | |
| 700 | 1 | _aRapp, E | |
| 700 | 1 | _aCrook, A F | |
| 700 | 1 | _aOrizaga, M | |
| 700 | 1 | _aSengar, D P | |
| 700 | 1 | _aRaman, S | |
| 773 | 0 |
_tAnnals of the New York Academy of Sciences _gvol. 277 _gno. 00 _gp. 436-66 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1749-6632.1976.tb41720.x _zAvailable from publisher's website |
| 999 |
_c1094363 _d1094363 |
||